InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by PETKANAS DEAN, Chairman & CEO. Insider active across 1 company, notably Neuropathix, INC.. Cumulatively, 6 disclosures have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €10k. History available since 29 July 2021. The latest transaction was disclosed on 6 June 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
10,000 shares@ US$0.0250.1% of flowCommon StockSEC:0001607062-22-000413:0
100,000 shares@ US$0.0261.5% of flowCommon StockSEC:0001607062-22-000403:0
89,000 shares@ US$0.0472.3% of flowCommon StockSEC:0001607062-22-000004
89,000 shares@ US$0.0472.3% of flowCommon StockSEC:0001607062-22-000004:0
1,875,000 shares@ US$0.04846.9% of flowCommon StockSEC:0001607062-21-000244
1,875,000 shares@ US$0.04846.9% of flowCommon StockSEC:0001607062-21-000244:0
6 of 6 declarations
About PETKANAS DEAN
Dean Petkanas is the Chief Executive Officer of Neuropathix, Inc. In this role, he is responsible for the strategic and operational leadership of the company. Petkanas implements initiatives aimed at driving growth and enhancing profitability. His leadership and vision are essential for achieving the long-term goals of Neuropathix.
